[Federal Register Volume 75, Number 56 (Wednesday, March 24, 2010)]
[Notices]
[Page 14172]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-6538]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and/or contract proposals 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with the grant 
applications and/or contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Nucleic Acid Analysis for the Molecular Characterization of 
Cancer.
    Date: April 6, 2010.
    Time: 1 p.m. to 6 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6116 Executive Boulevard, 
Room 706, Rockville, MD 20852. (Telephone Conference Call)
    Contact Person: Jeffrey E. DeClue, PhD, Scientific Review 
Officer, Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive 
Boulevard, Room 8059, Bethesda, MD 20892-8329. 301-496-7904. 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Probing DNA Damage and Repair Networks by Synthetic Lethal 
Screening.
    Date: April 8, 2010.
    Time: 1 p.m. to 6 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6116 Executive Boulevard, 
Room 210, Rockville, MD 20852. (Telephone Conference Call)
    Contact Person: Jeffrey E. DeClue, PhD, Scientific Review 
Officer, Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive 
Boulevard, Room 8059, Bethesda, MD 20892-8329. 301-496-7904. 
[email protected].
    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Development of Generic Cancer Antibodies for the Treatment of 
Cancer.
    Date: April 14, 2010.
    Time: 9 a.m. to 5 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6116 Executive Boulevard, 
Room 6006, Rockville, MD 20852. (Telephone Conference Call)
    Contact Person: Lalita D. Palekar, PhD, Scientific Review 
Officer, Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, 6116 Executive Boulevard, 
Room 7141, Bethesda, MD 20892. 301-496-7575. [email protected].
    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Cancer Center Support Grant.
    Date: May 7, 2010.
    Time: 8 a.m. to 12:45 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, 
MD 20814.
    Contact Person: Sonya Roberson, PhD, Scientific Review Officer, 
Resources and Training Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive Blvd., 
Room 8109, Bethesda, MD 20892-8328. 301-594-1182. 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: March 12, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-6538 Filed 3-23-10; 8:45 am]
BILLING CODE 4140-01-P